Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs
- PMID: 874815
Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs
Abstract
The aim of the present study was to investigate the possibility that catecholaminergic pathways within the central nervous system play a role in the control of renin secretion. Plasma renin activity (PRA) was measured after intravenous administration of L-dopa with and without prior inhibition of extracerebral dopa decarboxylase by carbidopa (MK-486) in pentobarbital-anesthetized dogs in which changes in renal perfusion pressure were minimized by means of a suprarenal aortic clamp. When L-dopa (20 mg/kg ) was administered intravenously without carbidopa. PRA and blood pressure increased. In contrast, administration of L-dopa (20 mg/kg i.v.) after blockade of extracerebral, but not cerebral dopa decarboxylase by intravenous carbidopa (20 mg/kg), produced significant decrease in both PRA and blood pressure. Larger doses of l-dopa (30-50) mg/kg i.v.) also lowered both PRA and blood presure in three carbidopa-treated animals, whereas a smaller dose of L-dopa (10 mg/kg i.v.) significantly lowered blood pressure but not PRA. In dogs with both kidneys acutely denervated, L-dopa (20 mg/kg i.v.) with carbidopa lowered arterial pressure but did not consistently alter PRA. These data suggest that catecholamines formed within the central nervous system can act to lower renin secretion as well as blood pressure.
Similar articles
-
Role of peripheral adrenoreceptors and vasopressin in the suppression of plasma renin activity by L-dopa in carbidopa-treated dogs.J Pharmacol Exp Ther. 1979 Sep;210(3):368-72. J Pharmacol Exp Ther. 1979. PMID: 480187
-
Age-dependent depressor effect of L-dopa in dogs with inhibition of extracerebral dopa decarboxylase.Pediatr Res. 1983 Nov;17(11):924-5. Pediatr Res. 1983. PMID: 6359046
-
Role of central and peripheral mechanisms in the action of alpha-methyldopa on blood pressure and renin secretion.J Pharmacol Exp Ther. 1977 May;201(2):400-5. J Pharmacol Exp Ther. 1977. PMID: 323462
-
An effect of extrarenal beta adrenergic stimulation on the release of renin.J Clin Invest. 1972 Jul;51(7):1861-9. doi: 10.1172/JCI106988. J Clin Invest. 1972. PMID: 4402350 Free PMC article.
-
Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.J Clin Invest. 1971 Jun;50(6):1322-8. doi: 10.1172/JCI106611. J Clin Invest. 1971. PMID: 5578236 Free PMC article.
Cited by
-
Plasmatic renin activity in patients treated with L-dopa and inhibitor of dopa decarboxylase (IDC).Psychopharmacology (Berl). 1979 Mar 22;61(2):197-202. doi: 10.1007/BF00426736. Psychopharmacology (Berl). 1979. PMID: 108737
-
Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.Br J Clin Pharmacol. 1986 May;21(5):497-502. doi: 10.1111/j.1365-2125.1986.tb02831.x. Br J Clin Pharmacol. 1986. PMID: 3087398 Free PMC article.
-
The effects of intravenous L-dopa on plasma renin activity, renal function, and blood pressure in man.Eur J Clin Pharmacol. 1988;35(2):137-41. doi: 10.1007/BF00609242. Eur J Clin Pharmacol. 1988. PMID: 3056728
-
The use of bromocriptine for testing central dopaminergic reactivity.Psychopharmacology (Berl). 1980;70(3):313-5. doi: 10.1007/BF00427893. Psychopharmacology (Berl). 1980. PMID: 6777808
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials